RHONDA BROWN: Open Payments
NPI 1881934842 · BAY CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 28 payments from 12 companies in 2025. Trend: 2023 $378 · 2024 $289 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Amgen Inc. | 5 | $83 |
| Novo Nordisk Inc | 1 | $76 |
| Lilly USA, LLC | 3 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Corcept Therapeutics | 2 | $43 |
| Astellas Pharma US Inc | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
Products named: FARXIGA, OTEZLA, Ozempic, JARDIANCE, Korlym, MOUNJARO, BREZTRI, Veozah.
Industry payments across TX — which companies pay providers there.
